OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Diabetologia (2016) Vol. 59, Iss. 6, pp. 1121-1140
Open Access | Times Cited: 588
Diabetologia (2016) Vol. 59, Iss. 6, pp. 1121-1140
Open Access | Times Cited: 588
Showing 1-25 of 588 citing articles:
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Chris Estes, Quentin M. Anstee, M. Arias, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 4, pp. 896-904
Open Access | Times Cited: 1584
Chris Estes, Quentin M. Anstee, M. Arias, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 4, pp. 896-904
Open Access | Times Cited: 1584
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
Kiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 9, pp. 851-861
Closed Access | Times Cited: 1313
Kiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 9, pp. 851-861
Closed Access | Times Cited: 1313
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1147
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1147
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Pοlyzos, Јannis Kountouras, Christos S. Mantzoros
Metabolism (2018) Vol. 92, pp. 82-97
Closed Access | Times Cited: 952
Stergios A. Pοlyzos, Јannis Kountouras, Christos S. Mantzoros
Metabolism (2018) Vol. 92, pp. 82-97
Closed Access | Times Cited: 952
NAFLD and diabetes mellitus
Herbert Tilg, Alexander R. Moschen, Michael Roden
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 14, Iss. 1, pp. 32-42
Closed Access | Times Cited: 846
Herbert Tilg, Alexander R. Moschen, Michael Roden
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 14, Iss. 1, pp. 32-42
Closed Access | Times Cited: 846
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 777
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 777
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 735
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 735
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles, José Manuel Fernández‐Real, Massimo Federici, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1070-1080
Open Access | Times Cited: 586
Lesley Hoyles, José Manuel Fernández‐Real, Massimo Federici, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1070-1080
Open Access | Times Cited: 586
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba, Eric Lawitz, Parvez Mantry, et al.
Hepatology (2017) Vol. 67, Iss. 2, pp. 549-559
Open Access | Times Cited: 501
Rohit Loomba, Eric Lawitz, Parvez Mantry, et al.
Hepatology (2017) Vol. 67, Iss. 2, pp. 549-559
Open Access | Times Cited: 501
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 402
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 402
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
Giovanni Targher, Herbert Tilg, Christopher D. Byrne
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 7, pp. 578-588
Open Access | Times Cited: 374
Giovanni Targher, Herbert Tilg, Christopher D. Byrne
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 7, pp. 578-588
Open Access | Times Cited: 374
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
Giovanni Musso, Maurizio Cassader, Elena Paschetta, et al.
JAMA Internal Medicine (2017) Vol. 177, Iss. 5, pp. 633-633
Open Access | Times Cited: 373
Giovanni Musso, Maurizio Cassader, Elena Paschetta, et al.
JAMA Internal Medicine (2017) Vol. 177, Iss. 5, pp. 633-633
Open Access | Times Cited: 373
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 348
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 348
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison, Stephen A. Harrison, Gad Cotter, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1322-1332
Closed Access | Times Cited: 319
Beth A. Davison, Stephen A. Harrison, Gad Cotter, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1322-1332
Closed Access | Times Cited: 319
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril, Kenneth Cusi
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 419-430
Open Access | Times Cited: 316
Fernando Bril, Kenneth Cusi
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 419-430
Open Access | Times Cited: 316
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Fernando Bril, Diane Biernacki, Srilaxmi Kalavalapalli, et al.
Diabetes Care (2019) Vol. 42, Iss. 8, pp. 1481-1488
Open Access | Times Cited: 275
Fernando Bril, Diane Biernacki, Srilaxmi Kalavalapalli, et al.
Diabetes Care (2019) Vol. 42, Iss. 8, pp. 1481-1488
Open Access | Times Cited: 275
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies
Nishanth E. Sunny, Fernando Bril, Kenneth Cusi
Trends in Endocrinology and Metabolism (2016) Vol. 28, Iss. 4, pp. 250-260
Closed Access | Times Cited: 273
Nishanth E. Sunny, Fernando Bril, Kenneth Cusi
Trends in Endocrinology and Metabolism (2016) Vol. 28, Iss. 4, pp. 250-260
Closed Access | Times Cited: 273
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 399-406
Open Access | Times Cited: 250
Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 399-406
Open Access | Times Cited: 250
Dietary Fructose and the Metabolic Syndrome
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 245
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 245
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease
Fernando Bril, Diana Barb, Paola Portillo-Sánchez, et al.
Hepatology (2016) Vol. 65, Iss. 4, pp. 1132-1144
Closed Access | Times Cited: 238
Fernando Bril, Diana Barb, Paola Portillo-Sánchez, et al.
Hepatology (2016) Vol. 65, Iss. 4, pp. 1132-1144
Closed Access | Times Cited: 238
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019)
Jürgen Harreiter, Michael Roden
Wiener klinische Wochenschrift (2019) Vol. 131, Iss. S1, pp. 6-15
Closed Access | Times Cited: 209
Jürgen Harreiter, Michael Roden
Wiener klinische Wochenschrift (2019) Vol. 131, Iss. S1, pp. 6-15
Closed Access | Times Cited: 209
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 203
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 203
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis
Marco Castellana, Eleonora Conte, Angelo Cignarelli, et al.
Reviews in Endocrine and Metabolic Disorders (2019) Vol. 21, Iss. 1, pp. 5-16
Closed Access | Times Cited: 199
Marco Castellana, Eleonora Conte, Angelo Cignarelli, et al.
Reviews in Endocrine and Metabolic Disorders (2019) Vol. 21, Iss. 1, pp. 5-16
Closed Access | Times Cited: 199
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1881-1898
Open Access | Times Cited: 186
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1881-1898
Open Access | Times Cited: 186
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
Fernando Bril, Srilaxmi Kalavalapalli, Virginia Clark, et al.
Clinical Gastroenterology and Hepatology (2017) Vol. 16, Iss. 4, pp. 558-566.e2
Closed Access | Times Cited: 181
Fernando Bril, Srilaxmi Kalavalapalli, Virginia Clark, et al.
Clinical Gastroenterology and Hepatology (2017) Vol. 16, Iss. 4, pp. 558-566.e2
Closed Access | Times Cited: 181
